|
|
Vaccine Information Statements |
|
|
|
|
|
|
|
November 18, 2008 |
|
|
|
|
|
| |
Up-to-date translations |
|
|
|
| You
are encouraged to distribute the up-to-date English-language
VIS at the same time as the translation. |
|
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
|
|
|
|
| Tdap vaccine is used in persons ages 10-64 years. |
|
| Tdap VIS was replaced on November 18, 2008 with the Td/Tdap VIS |
|
| The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs. |
|
|
|
| These translations do not
contain the following CDC updates: |
|
| • |
|
CDC added recommending vaccination of children aged 24-59 months and their contacts. |
|
|
|
| • |
|
Section 3: CDC added to the list of people at high risk for complications from influenza, "People with certain muscle or nerve disorders (such as seizure disorders or severe cerebral palsy) that can lead to breathing or swallowing disorders." |
|
|
|
|
|
|
| Td vaccine is used in persons ages 7 years and older. |
|
| Td VIS was replaced on November 18, 2008 with the Td/Tdap VIS |
|
| The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs. |
|
|